Found: 20
Select item for more details and to access through your institution.
Effect of Laser Panretinal Photocoagulation Combined with Lucentis on Long-Term Visual Acuity of Patients with Retinal Arterial Macroaneurysm.
- Published in:
- Alternative Therapies in Health & Medicine, 2023, v. 29, n. 8, p. 412
- By:
- Publication type:
- Article
Association Between Intravitreal Aflibercept and Serious Non-ocular Haemorrhage Compared with Intravitreal Ranibizumab: A Multicentre Observational Cohort Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Case of Idiopathic Peripapillary Subretinal Neovascular Membrane in an otherwise Healthy Young Male: A Case report.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Spectral-luminescent study of a hydrogel based on hyaluronic acid dialdehyde and chitosan succinate containing the Lucentis drug.
- Published in:
- High Energy Chemistry, 2018, v. 52, n. 1, p. 34, doi. 10.1134/S0018143918010083
- By:
- Publication type:
- Article
Intravitreal bevacizumab.
- Published in:
- 2018
- By:
- Publication type:
- letter
A Retrospective Analysis of the Real-Life Utilization of Ranibizumab in Patients with Wet Age-Related Macular Degeneration from Portugal.
- Published in:
- Acta Médica Portuguesa, 2017, v. 30, n. 6, p. 449, doi. 10.20344/amp.8217
- By:
- Publication type:
- Article
Effect of anti-VEGF drugs combined with photodynamic therapy in the treatment of age-related macular degeneration.
- Published in:
- Experimental & Therapeutic Medicine, 2016, v. 12, n. 6, p. 3923, doi. 10.3892/etm.2016.3886
- By:
- Publication type:
- Article
The effects of VEGF-A-inhibitors aflibercept and ranibizumab on the ciliary body and iris of monkeys.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2016, v. 254, n. 6, p. 1117, doi. 10.1007/s00417-016-3344-8
- By:
- Publication type:
- Article
Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration.
- Published in:
- Clinical Interventions in Aging, 2016, v. 11, p. 357, doi. 10.2147/CIA.S93820
- By:
- Publication type:
- Article
Criteria for Drug Pricing: Preliminary Experiences with Modeling the Price -Volume Relationship.
- Published in:
- Scientia Pharmaceutica, 2016, v. 84, n. 1, p. 73, doi. 10.3797/scipharm.1506-03
- By:
- Publication type:
- Article
High-dose ranibizumab monotherapy for neovascular polypoidal choroidal vasculopathy in a predominantly non-Asian population.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Evaluating the impact of summer vacation on the visual acuity of AMD patients treated with ranibizumab.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Pluronic F127 as a drug vehicle used in chick embryo chorioallantoic membrane shell-less model.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2015, v. 28, n. 6, p. 1997
- By:
- Publication type:
- Article
FDA approves Lucentis for diabetic retinopathy.
- Published in:
- Optometry Times, 2015, v. 7, n. 3, p. 24
- Publication type:
- Article
Single-session photodynamic therapy combined with intravitreal ranibizumab for neovascular age-related macular degeneration: a comprehensive functional retinal assessment.
- Published in:
- Documenta Ophthalmologica, 2013, v. 127, n. 3, p. 217, doi. 10.1007/s10633-013-9404-z
- By:
- Publication type:
- Article
Yaşa Bağlı Maküla Dejeneresansında Ranibizumab Tedavisinin Uzun Dönem Sonuçları.
- Published in:
- Retina-Vitreus/Journal of Retina-Vitreous, 2013, v. 21, n. 3, p. 178
- By:
- Publication type:
- Article
Retreatment by series of three intravitreal injections of ranibizumab in neovascular age-related macular degeneration: long-term outcomes.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2013, v. 251, n. 8, p. 1901, doi. 10.1007/s00417-013-2284-9
- By:
- Publication type:
- Article
Bevacizumab versus ranibizumab: why are we not playing the joker?
- Published in:
- International Journal of Clinical Pharmacy, 2013, v. 35, n. 4, p. 507, doi. 10.1007/s11096-013-9779-7
- By:
- Publication type:
- Article
Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration.
- Published in:
- Current Medical Literature: Ophthalmology, 2013, v. 23, n. 2, p. 71
- By:
- Publication type:
- Article
Intravitreal ranibizumab, with or without filter?
- Published in:
- Acta Ophthalmologica (1755375X), 2012, v. 90, n. 5, p. e405, doi. 10.1111/j.1755-3768.2011.02278.x
- By:
- Publication type:
- Article